GO:0022009 central nervous system vasculogenesis: Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0022009 central nervous system vasculogenesis describes the de novo formation of blood vessels in the central nervous system (CNS) from endothelial progenitor cells, a process that establishes the specialized blood-brain barrier (BBB).
• The process begins with differentiation of endothelial progenitors, followed by sprouting, tube formation, and recruitment of pericytes and astrocytes to stabilize the CNS vasculature.
• Key genes include VEGFA, FLT1, KDR, PECAM1, CDH5, CLDN5, OCLN, PDGFRB, and NOTCH1, which regulate endothelial proliferation, junction formation, and barrier properties.
• Disruption of CNS vasculogenesis is linked to brain arteriovenous malformations, encephalocraniocutaneous lipomatosis, and BBB dysfunction in neurological disorders.
• Human embryonic and neural organoid models are powerful systems to study CNS vasculogenesis and BBB formation in vitro.
• CRISPR-based knockout, knock-in, and overexpression models enable causal interrogation of genes driving CNS vascular development and disease.
Description
Central nervous system (CNS) vasculogenesis is the developmental process by which endothelial progenitor cells differentiate and assemble into new blood vessels within the brain and spinal cord, ultimately forming the blood-brain barrier (BBB). This process is distinct from angiogenesis, which involves sprouting from pre-existing vessels, and is critical for supplying oxygen and nutrients to the developing CNS while protecting it from harmful substances. Understanding CNS vasculogenesis is essential for researchers studying neurovascular development, BBB function, and diseases such as brain arteriovenous malformations and neurodegenerative disorders. Recent advances in human embryo studies and neural organoid models have shed light on the cellular and molecular mechanisms underlying this process, revealing conserved and human-specific features. This article provides a comprehensive overview of GO:0022009, covering its definition, key genes, regulatory mechanisms, disease relevance, and cutting-edge research methods including CRISPR-based approaches.
central nervous system vasculogenesis At A Glance
| GO ID | GO:0022009 |
|---|---|
| GO term | central nervous system vasculogenesis |
| Ontology | biological_process |
| Synonym | None |
| Major function | De novo formation of blood vessels in the CNS and establishment of the blood-brain barrier |
| Related process | Angiogenesis, endothelial cell differentiation, blood-brain barrier development |
| Key cell types | Endothelial cells, pericytes, astrocytes |
| Disease relevance | Brain arteriovenous malformations, encephalocraniocutaneous lipomatosis, BBB dysfunction |
What Is GO:0022009?
GO:0022009 central nervous system vasculogenesis is defined as the differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes in the central nervous system. The capillary endothelial cells in the brain are specialized to form the blood-brain barrier, a unique feature of CNS vasculature.
Why Is central nervous system vasculogenesis Important in Cell Biology?
CNS vasculogenesis is fundamental for brain development and function, as it establishes the blood-brain barrier that protects the CNS from toxins and pathogens while supplying essential nutrients. Defects in this process can lead to severe neurovascular disorders, including brain arteriovenous malformations and encephalocraniocutaneous lipomatosis, and contribute to BBB breakdown in neurodegenerative diseases. Studying CNS vasculogenesis provides insights into human-specific developmental mechanisms and offers targets for therapeutic intervention in neurovascular diseases.
• Establishes the blood-brain barrier, essential for CNS homeostasis and protection.
• Defects cause brain arteriovenous malformations, a leading cause of hemorrhagic stroke.
• Implicated in encephalocraniocutaneous lipomatosis, a rare neurocutaneous disorder.
• BBB dysfunction is a hallmark of neurodegenerative diseases like Alzheimer's and Parkinson's.
• Provides a model to study human-specific vascular development using organoids.
• Key for drug delivery to the brain, as BBB restricts most therapeutics.
• Involves signaling pathways (VEGF, Notch, Apelin) that are targets for modulation.
• Human neural organoids recapitulate CNS vasculogenesis, enabling disease modeling.
• CRISPR screening can identify novel regulators of CNS vascular development.
• Understanding CNS vasculogenesis aids in engineering vascularized brain tissue for regenerative medicine.
What Happens During central nervous system vasculogenesis?
Endothelial progenitor differentiation
In simple terms: Stem-like cells become blood vessel lining cells.
During early CNS development, endothelial progenitor cells (angioblasts) differentiate into endothelial cells in response to signals such as VEGF-A. This step is marked by the expression of endothelial markers like CDH5 (VE-cadherin) and PECAM1 (CD31). In human embryos, this process begins around Carnegie stage 14 and is recapitulated in neural organoids.
Sprouting and tube formation
In simple terms: New blood vessels sprout and form tubes.
Differentiated endothelial cells proliferate and migrate to form primary vascular plexuses, then undergo sprouting and anastomosis to create a network of tubes. This step involves tip cells and stalk cells, regulated by Notch signaling and VEGF gradients. The resulting vessels are initially leaky and require stabilization.
Recruitment of pericytes and astrocytes
In simple terms: Support cells wrap around vessels to strengthen them.
Pericytes and astrocytes are recruited to nascent vessels, where they promote barrier formation and vessel stabilization. Pericytes derived from the neural crest and mesoderm cover endothelial tubes, while astrocytes extend endfeet to ensheath capillaries. This interaction is critical for inducing BBB properties.
Blood-brain barrier specialization
In simple terms: Vessels become a tight barrier that protects the brain.
CNS endothelial cells develop specialized tight junctions (e.g., claudin-5, occludin) and express transporters that regulate nutrient and waste exchange. This barrier function is induced by interactions with pericytes and astrocytes, and is a hallmark of CNS vasculature. In vitro models using endothelial cells, pericytes, and astrocytes self-organize into microvascular structures that mimic the BBB.
Vascular remodeling and maturation
In simple terms: The vessel network is refined and stabilized.
After initial formation, the vascular network undergoes remodeling, including pruning of unnecessary vessels and stabilization of mature ones. This process involves blood flow-dependent signals and extracellular matrix remodeling. Mature CNS vessels are characterized by low permeability and high expression of tight junction proteins.
Key Genes Involved in GO:0022009 central nervous system vasculogenesis
The following genes are key regulators of central nervous system vasculogenesis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFA | Promotes endothelial proliferation and sprouting | Target for modulating CNS vascular growth |
| FLT1 (VEGFR1) | Decoy receptor for VEGF, modulates angiogenesis | Regulates vascular patterning in CNS |
| KDR (VEGFR2) | Main receptor for VEGF signaling | Essential for endothelial differentiation |
| PECAM1 (CD31) | Endothelial cell adhesion and migration | Marker for endothelial cells in CNS vasculature |
| CDH5 (VE-cadherin) | Endothelial cell-cell junctions | Critical for vascular integrity and BBB |
| CLDN5 | Tight junction protein in BBB | Key for barrier function |
| OCLN | Tight junction protein in BBB | Regulates paracellular permeability |
| PDGFRB | Pericyte recruitment and proliferation | Important for vessel stabilization |
| NOTCH1 | Regulates tip/stalk cell fate | Controls sprouting angiogenesis |
| DLL4 | Notch ligand, regulates sprouting | Modulates vascular density |
| APLN | Apelinergic signaling in vascular development | Role in pregnancy and vascular tone |
| APLNR | Apelin receptor, regulates endothelial function | Potential target in vascular disorders |
| TIE1 | Endothelial receptor tyrosine kinase | Regulates vascular stability |
| TEK (TIE2) | Angiopoietin receptor | Controls vessel maturation |
| ANGPT1 | Angiopoietin-1, stabilizes vessels | Promotes pericyte recruitment |
| ANGPT2 | Angiopoietin-2, destabilizes vessels | Regulates vascular remodeling |
| FOXO1 | Transcription factor in endothelial cells | Modulates angiogenesis and barrier |
How Is central nervous system vasculogenesis Regulated?
CNS vasculogenesis is regulated by a complex interplay of signaling pathways, including VEGF, Notch, Angiopoietin-Tie, and Apelinergic systems. VEGF-A gradients guide sprouting and proliferation, while Notch signaling determines tip versus stalk cell fate. The Apelinergic system, involving APLN and APLNR, modulates vascular tone and has been implicated in pregnancy-related vascular adaptations. Additionally, hemodynamic forces and extracellular matrix interactions influence vessel remodeling and maturation. Transcriptional regulators such as FOXO1 integrate these signals to control endothelial gene expression.
central nervous system vasculogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ENG | Hereditary hemorrhagic telangiectasia / AVM | Knockout endothelial cells, organoid model |
| ACVRL1 | Hereditary hemorrhagic telangiectasia / AVM | Point mutation knock-in mice |
| SMAD4 | AVM and vascular dysplasia | Conditional knockout in CNS endothelium |
| CLDN5 | BBB dysfunction in neurodegeneration | Knockout or knockdown in BBB models |
| PDGFRB | Pericyte deficiency and BBB breakdown | Knockout mice or pericyte co-culture |
Brain arteriovenous malformations (AVMs)
Brain AVMs are abnormal tangles of blood vessels that can rupture and cause hemorrhagic stroke. They are thought to arise from defects in vascular development, including dysregulated angiogenesis and vasculogenesis. Mutations in genes such as ENG, ACVRL1, and SMAD4 have been linked to hereditary hemorrhagic telangiectasia, a condition predisposing to AVMs. Studying CNS vasculogenesis can reveal mechanisms of AVM formation and potential therapeutic targets.
Encephalocraniocutaneous lipomatosis (ECCL)
ECCL is a rare neurocutaneous disorder characterized by lipomas, skin lesions, and CNS anomalies, including vascular malformations. Although the genetic cause is not fully understood, it is hypothesized to involve dysregulation of vascular development. Research into CNS vasculogenesis may provide insights into ECCL pathogenesis.
Blood-brain barrier dysfunction in neurodegeneration
BBB breakdown is an early event in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis. Impaired CNS vasculogenesis or maintenance can lead to BBB leakage, allowing neurotoxic molecules to enter the brain. Understanding the molecular regulators of BBB formation may lead to therapies that restore barrier integrity.
From central nervous system vasculogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate endothelial differentiation in CNS? | CRISPR knockout in human neural organoids |
| Does a point mutation in gene Y affect BBB integrity? | Point mutation knock-in in iPSC-derived endothelial cells |
| Can overexpression of gene Z enhance vascularization? | Overexpression in endothelial cells or organoids |
| What is the role of gene W in pericyte recruitment? | Tagged knock-in for lineage tracing |
| Which genes are essential for CNS vasculogenesis? | CRISPR library screening in organoid models |
| How does gene V mutation affect vessel morphology? | Knock-in of patient-specific mutation in mice |
How to Study the central nervous system vasculogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Gene expression profiles of individual cells | Identify endothelial subtypes during CNS vasculogenesis |
| Light-sheet microscopy | 3D vascular architecture | Visualize sprouting and tube formation in organoids |
| CRISPR knockout screening | Gene function on vascular development | Discover novel regulators |
| Permeability assays | Barrier function of endothelial monolayers | Assess BBB integrity in vitro |
| Immunostaining | Protein localization and expression | Characterize tight junctions and pericyte coverage |
| Flow cytometry | Cell surface marker expression | Isolate endothelial progenitors |
| Proteomics | Protein abundance and modifications | Study signaling pathways in vasculogenesis |
Human embryonic and organoid models
Human embryos and neural organoids provide a platform to study CNS vasculogenesis in a species-specific context. Organoids derived from pluripotent stem cells can self-organize into vascular-like structures when co-cultured with endothelial cells or subjected to vascular induction. These models recapitulate key steps of BBB formation and can be used for genetic manipulation.
3D microvascular BBB models
In vitro 3D models using endothelial cells, pericytes, and astrocytes self-assemble into microvascular networks that mimic the BBB. These models allow real-time imaging and permeability assays to study barrier function and the effects of genetic perturbations.
CRISPR screening and functional genomics
CRISPR-based knockout screens in endothelial cells or organoids can identify novel regulators of CNS vasculogenesis. Pooled screens with next-generation sequencing enable unbiased discovery of genes affecting vascular development.
Imaging and transcriptomics
Advanced imaging techniques such as light-sheet microscopy and single-cell RNA sequencing allow visualization and molecular profiling of developing CNS vasculature. These methods reveal cellular heterogeneity and dynamic gene expression during vasculogenesis.
How CRISPR Can Be Used to Study GO:0022009 central nervous system vasculogenesis
Knockout
CRISPR knockout of candidate genes in human neural organoids or endothelial cells can determine their necessity for CNS vasculogenesis. For example, knocking out CLDN5 abolishes tight junction formation and BBB function. Pooled knockout screens enable unbiased identification of essential genes.
Point Mutation
Introducing patient-specific point mutations (e.g., in ENG or ACVRL1) via CRISPR knock-in allows modeling of vascular malformations and studying the impact on endothelial function. Point mutations can reveal dominant-negative or loss-of-function effects.
Knock-in
Knock-in of reporter genes (e.g., GFP) or tags into endogenous loci enables lineage tracing and live imaging of endothelial cells during CNS vasculogenesis. This approach can also be used to express mutant proteins under native regulation.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of pro-angiogenic factors such as VEGFA can enhance vascularization in organoid models. Overexpression studies help identify sufficiency of a gene to drive CNS vasculogenesis.
How EDITGENE Supports central nervous system vasculogenesis Research
Researchers studying central nervous system vasculogenesis-related genes often need to determine whether a candidate gene is causally involved in endothelial differentiation, barrier formation, or vascular malformations. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell and organoid models, enabling functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for central nervous system vasculogenesis research.
Frequently Asked Questions About central nervous system vasculogenesis
What is central nervous system vasculogenesis?
Central nervous system vasculogenesis (GO:0022009) is the process by which endothelial progenitor cells differentiate and form new blood vessels in the brain and spinal cord, establishing the blood-brain barrier.
What genes are involved in central nervous system vasculogenesis?
Key genes include VEGFA, FLT1, KDR, PECAM1, CDH5, CLDN5, OCLN, PDGFRB, NOTCH1, DLL4, APLN, and APLNR, among others.
How is central nervous system vasculogenesis studied?
It is studied using human embryos, neural organoids, 3D BBB models, CRISPR screens, and imaging techniques like single-cell RNA-seq and light-sheet microscopy.
What diseases are linked to defects in CNS vasculogenesis?
Defects are linked to brain arteriovenous malformations, encephalocraniocutaneous lipomatosis, and blood-brain barrier dysfunction in neurodegeneration.
What is the role of the blood-brain barrier in CNS vasculogenesis?
The blood-brain barrier is a specialized feature of CNS endothelial cells that restricts permeability and is established during vasculogenesis through interactions with pericytes and astrocytes.
Can CRISPR be used to study CNS vasculogenesis?
Yes, CRISPR knockout, knock-in, and overexpression models in organoids and endothelial cells enable functional studies of genes involved in CNS vasculogenesis.
What are the stages of central nervous system vasculogenesis?
Stages include endothelial progenitor differentiation, sprouting and tube formation, pericyte and astrocyte recruitment, BBB specialization, and vascular remodeling.
Why is CNS vasculogenesis important for drug delivery?
The BBB formed during CNS vasculogenesis restricts drug penetration into the brain, making it a major challenge for delivering therapeutics to the CNS.
What signaling pathways regulate CNS vasculogenesis?
VEGF, Notch, Angiopoietin-Tie, and Apelinergic signaling pathways regulate CNS vasculogenesis.
How do organoids model CNS vasculogenesis?
Neural organoids can self-organize vascular-like structures and mimic BBB formation, providing a human-relevant model for studying CNS vasculogenesis.
Conclusion
Central nervous system vasculogenesis (GO:0022009) is a critical developmental process that forms the brain's vascular network and establishes the blood-brain barrier. Dysregulation of this process contributes to neurovascular diseases, making it a key area of research. Advances in human organoid models and CRISPR technologies are accelerating our understanding of the genetic and molecular mechanisms involved. EDITGENE provides comprehensive CRISPR services to support functional studies and therapeutic development in this field.
References
- 1. Boutom SM et al.. 2024. Central nervous system vascularization in human embryos and neural organoids.. Cell Rep 43(12):115068 PMID: 39693224
- 2. Lawton MT et al.. 2015. Brain arteriovenous malformations.. Nat Rev Dis Primers 1:15008 PMID: 27188382
- 3. Salewskij K et al.. 2023. Blood Vessel Organoids for Development and Disease.. Circ Res 132(4):498-510 PMID: 36795852
- 4. Campisi M et al.. 2018. 3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes.. Biomaterials 180:117-129 PMID: 30032046
- 5. Moog U. 2009. Encephalocraniocutaneous lipomatosis.. J Med Genet 46(11):721-9 PMID: 19574261
- 6. Pécheux O et al.. 2023. The Apelinergic System in Pregnancy.. Int J Mol Sci 24(9) PMID: 37175743
- 7. Yao Y et al.. 2021. Brain vascular biology.. Handb Clin Neurol 176:49-69 PMID: 33272410
- 8. Pries AR et al.. 2006. Normal endothelium.. Handb Exp Pharmacol PMID: 16999215
